Point of care lab testing is well-known to the CLIA-waived market, and many doctors check simple blood and urine chemistries right in the office. But molecular tests based on DNA amplification require expensive machinery, and are usually “send outs” for the independent physician. Key innovations in low-cost bedside DNA amplification (qPCR) will allow just about any doctor to have a molecular diagnostics lab in his pocket.